Advertisement
Advertisement

MAIA

MAIA logo

MAIA Biotechnology Inc

1.98
USD
-0.22
-10.00%
Dec 18, 15:53 UTC -5
Closed
...

MAIA Biotechnology Inc Profile

About

MAIA Biotechnology Inc. is a clinical-stage biopharmaceutical company developing targeted immunotherapies for cancer. The Company's lead program is THIO, a potential first-in-class cancer telomere targeting agent in clinical development for the treatment of patients with telomerase-positive cancers. MAIA Biotechnology Inc. is based in CHICAGO.

Info & Links

CEO

Vlad Vitoc

Headquarters

444 WEST LAKE STREET, SUITE 1700
CHICAGO, IL 60606, UNITED STATES

Auditor

GRANT THORNTON LLP

Share holders

136

Employees

13

MAIA Biotechnology Inc Statistics

Valuation Measures

Market Capitalization2

50.15M

Enterprise Value

41.46M

Enterprise Value/EBITDA(ttm)

-2.26

Price to Earnings Ratio(ttm)

--

Price to Sales(ttm)

--

Price to Book(mrq)

29.53

Price to Cash(ytd)

--

Profitability

Gross Margin(ttm)

0.00%

Operating Margin(ttm)

--

Profit Margin(ttm)

0.00%

Return on Equity(ttm)

-14708.83%

Return on Invested Capital(ttm)

-1620.18%

Return on Assets(ttm)

-221.26%

Income Statement

Revenue(ttm)

0.00

Revenue Per Share(ttm)

0.00

Gross Profit(ttm)

0.00

EBITDA(ttm)3

-18.33M

Net Income Available to Common(ttm)

-25.94M

Diluted EPS(ttm)

-1.38

Share Statistics

Beta (5Y Monthly)

0.14

52-Week Change

120.00%

S&P 500 52-Week Change

23.87%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding1

25.33M

Dividend Yield

0.00%

Float4

15.96M

% Held by Insiders

36.98%

% Held by Institutions

5.65%

Balance Sheet

Total Cash(mrq)

8.69M

Total Cash Per Share(mrq)

0.34

Total Debt(mrq)

0.00

Total Debt/Equity(mrq)

0.00%

Current Ratio(mrq)

2.56%

Quick Ratio(mrq)

2.56%

Book Value Per Share(mrq)

0.07

Cash Flow

Operating Cash Flow Per Share(ytd)

-0.49

Free Cash Flow(ytd)

-11.80M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement